Get the Stockscreener App
0.403
3.33%
0.013
BiomX Inc stock is traded at $0.403, with a volume of 693.81K.
It is up +3.33% in the last 24 hours and down -29.17% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.39
Open:
$0.39
24h Volume:
693.81K
Relative Volume:
0.69
Market Cap:
$10.70M
Revenue:
-
Net Income/Loss:
$-23.14M
P/E Ratio:
-0.3978
EPS:
-1.0131
Net Cash Flow:
$-29.23M
1W Performance:
-18.42%
1M Performance:
-29.17%
6M Performance:
-29.91%
1Y Performance:
-50.36%
1-Day Range:
$0.385
$0.4069
1-Week Range:
$0.385
$0.5052
52-Week Range:
$0.34
$1.1609
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.403 | 10.36M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Forecasting BiomX Inc. price range with options dataJuly 2025 PostEarnings & Consistent Profit Focused Trading Strategies - newser.com
Why BiomX Inc. stock could be top winner2025 Sector Review & Growth Focused Stock Pick Reports - newser.com
How BiomX Inc. stock reacts to inflationary pressuresIPO Watch & Target Return Focused Stock Picks - newser.com
How BiomX Inc. stock compares with tech leadersPortfolio Performance Summary & Capital Protection Trading Alerts - newser.com
Why BiomX Inc. stock remains resilientWeekly Market Outlook & Smart Investment Allocation Tips - newser.com
Signal strength of BiomX Inc. stock in tech scannersTrade Signal Summary & Daily Chart Pattern Signal Reports - newser.com
What recovery options are there for BiomX Inc.July 2025 Review & Weekly High Potential Alerts - newser.com
Strategies to average down on BiomX Inc.July 2025 Analyst Calls & Community Verified Swing Trade Signals - newser.com
Will BiomX Inc. stock gain from green policiesJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Using RSI to spot recovery in BiomX Inc.July 2025 Update & Verified Momentum Stock Watchlist - newser.com
Will BiomX Inc. stock split attract more investorsJuly 2025 Pullbacks & Accurate Entry/Exit Alerts - fcp.pa.gov.br
Predicting BiomX Inc. trend using moving averages2025 Pullback Review & Advanced Technical Analysis Signals - newser.com
Published on: 2025-11-06 02:03:08 - newser.com
BiomX to Report Third Quarter 2025 Financial Results and Program Updates on November 12, 2025 - The Globe and Mail
Will BiomX Inc. stock draw ESG focused fundsJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
What Wall Street predicts for BiomX Inc. stock priceJuly 2025 Highlights & Capital Efficient Trading Techniques - fcp.pa.gov.br
BiomX (NYSE American: PHGE) schedules Nov. 12 third‑quarter call at 8:30 a.m. ET - Stock Titan
BiomX announces FDA feedback on development pathway for BX011 - MSN
Will BiomX Inc. stock rise with strong economyCPI Data & Free Community Supported Trade Ideas - newser.com
Is BiomX Inc. stock cheap at current valuationJuly 2025 Breakouts & Fast Gain Swing Alerts - newser.com
Analyzing BiomX Inc. with multi timeframe chartsWeekly Trade Summary & Free AI Powered Buy and Sell Recommendations - newser.com
Full technical analysis of BiomX Inc. stockMarket Sentiment Summary & Daily Profit Focused Screening - newser.com
BiomX (PHGE) Gains FDA Support for BX011 in Diabetic Foot Infection Treatment - GuruFocus
BiomX Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections - The Manila Times
BiomX Inc. Announces Positive FDA Feedback Supporting Next-Generation Phage Cocktail Program for Diabetic Foot Infections - MarketScreener
Why BiomX Inc. stock remains stableBreakout Watch & Free Risk Controlled Daily Trade Plans - newser.com
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.44%
0.70%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):